2d
Her Campus on MSNMikayla Nogueira’s Skin Care Line Is Coming & Here’s What To KnowI'm sat. The post Mikayla Nogueira’s Skin Care Line Is Coming & Here’s What To Know first appeared on Her Campus.
Promising Nonalcoholic Steatohepatitis Therapies such as AZD2693, Saroglitazar Magnesium 4 mg, Semaglutide (SEMA), Cilofexor ...
Clene, Inc. (Nasdaq: CLNN) and its subsidiary, Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company focused on revolutionizing the treatment ...
Among participants who met the core RESTORE-ALS Trial criteria (e.g., baseline serum NfL > 33 pg/mL, TRICALS risk score range between –6.5 and –2.5, baseline slow vital capacity > 60%, and symptom ...
Gilead Sciences, Inc. today announced the presentation of late-breaking data and multiple oral presentations from its innovative HIV treatment portfolio and pipeline at the Conference on Retroviruses ...
Clene (CLNN) and its subsidiary, Clene Nanomedicine announced new evidence from a cross-regimen, post hoc analysis of long-term survival in ...
NDB Bank celebrates International Women’s Day with Araliya Medical Camp and free healthcare services
NDB Bank marked International Women’s Day by hosting the Araliya Medical Camp, a special event that brought together around 200 Araliya Women’s Account holders at the Bank’s premises on March 8. This ...
Aim Vaccine Co. Ltd. may become the first company to gain regulatory clearance of a prophylactic iterative serum-free human rabies vaccine. Beijing-based Aim said it is preparing a regulatory ...
This paper presents the important finding that BNIP3/NIX, a mitophagy receptor, and its binding to ATG18 are required for mitophagy during muscle cell reorganization in Drosophila. Although the ...
Gradually, high blood sugar can cause these vessels to become narrow. When the blood vessels are clogged or narrowed, the kidneys can’t function properly and purify the blood effectively. As a result, ...
Additionally, the prognosis of macular edema may help clinicians evaluate renal function, investigators reported ...
Harrow , a leading North American eyecare pharmaceutical company, announced the execution of a five-year strategic supply and development ("SSD") agreement for TRIESENCE® (triamcinolone acetonide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results